ID   NCC-GCTB5-C1
AC   CVCL_C1GF
DR   Wikidata; Q114312459
RX   PubMed=35653034;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 32 hours (PubMed=35653034).
CC   Sequence variation: Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=35653034).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): PubMed=35653034
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 11,13
ST   D21S11: 31.2
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,16,17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 5
//
RX   PubMed=35653034; DOI=10.1007/s13577-022-00724-2;
RA   Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T.,
RA   Fukushima S., Toda Y., Kojima N., Yoshida A., Ohtori S., Kawai A.,
RA   Kondo T.;
RT   "Establishment and characterization of NCC-GCTB5-C1: a novel cell line
RT   of giant cell tumor of bone.";
RL   Hum. Cell 35:1621-1629(2022).
//